Argyreia nervosa exposures reported to Texas poison centers.
Mathias B. Forrester
Journal of Addictive Diseases 2018 DOI: 10.1080/10550887.2019.1640057 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Retrospective case series Case report Peer reviewed |
|---|---|
| Sample size | 29 |
| Population | People with Argyreia nervosa (Hawaiian baby woodrose) seed exposures reported to Texas poison centers, 2000-2018 |
| Keywords | Argyreia nervosa Hawaiian baby woodrose Lysergic acid amine Poison center |
| Key findings | Of 29 Argyreia nervosa seed exposures reported to Texas poison centers, 38% had moderate and 7% major medical effects, while 31% had minor effects and 3% no effect. Gastrointestinal (45%) and neurological (41%) effects were most frequent, and common treatments were intravenous fluids (28%) and benzodiazepines (21%). |
Abstract
The seeds of Argyreia nervosa (Hawaiian baby woodrose) contain lysergamide or lysergic acid amine, an analog for lysergic acid diethylamide. Twenty-nine Argyreia nervosa exposures reported to Texas poison centers during 2000-2018 were identified. Seventy-nine percent of the patients were male; the mean age was 24 years (range 16-53 years). The exposure route was 97% ingestion and 3% inhalation. Ninety-three percent of the exposures occurred at the patient's own residence and 3% at another residence. Fourteen percent of the patients were managed on-site, 69% were already at or en route to a healthcare facility when the poison center was contacted, and 17% were referred to a healthcare facility by the poison center. The medical outcome was 3% no effect, 31% minor effect, 38% moderate effect, 7% major effect, 7% not followed-minimal clinical effects possible, and 14% unable to follow-potentially toxic. The most frequent clinical effects were gastrointestinal (45%) and neurological (41%). The most frequently reported treatments were administration of intravenous fluids (28%) and benzodiazepines (21%).
Citations in the library
Cited by 2
Cites 4
- Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016 Journal of Psychopharmacology September 5, 2018
- Recreational use of D-lysergamide from the seeds of Argyreia nervosa, Ipomoea tricolor, Ipomoea violacea, and Ipomoea purpurea in Poland. Journal of Psychoactive Drugs 2013
- Variable adverse effects in subjects after ingestion of equal doses of Argyreia nervosa seeds. Forensic Science International January 10, 2012
- [Hawaiian baby rose wood: case report of an argyreia nervosa induced toxic psychosis]. Psychiatrische Praxis May 2003